Stroke Trial, Recruiting NCT04750564 Sponsor: The University of Texas Health Science Center, Houston Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04750564
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke at least 6 months ago and are currently in a stable medical condition
  • People who have had a single stroke affecting one side of the body only (both ischemic — caused by a blockage — and hemorrhagic — caused by bleeding — strokes are considered, regardless of the stroke's size)
  • People who have some detectable stiffness or increased muscle tension in their finger flexors (the muscles that curl the fingers), as measured by a standard clinical scale

Who may not be able to join:

  • People who have problems with their vision, difficulty paying attention to one side of their environment, hearing difficulties, or cognitive (thinking and memory) problems
  • People who have a history of lung conditions such as asthma or chronic obstructive pulmonary disease (COPD)
  • People who are currently in the process of changing medications used to manage muscle stiffness or tone (for example, baclofen)
  • People who have received botulinum toxin (such as Botox) injections to the arm or fingers within the last 4 months, or phenol injections within the last 2 years
  • People who have a pacemaker (a device implanted in the chest to help regulate the heartbeat)
  • People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheng Li, MD, PhD, University of Texas

Phone: (713) 797-7125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov